Drs Ursula A. Matulonis and Gini F. Fleming discuss the state of endometrial cancer, the role of immunotherapy, and priorities for research in this field.

A retrospective study showed that either folate receptor alpha or B7-H4 was expressed in more than 80% of endometrial cancers ...

Neoadjuvant nivolumab has demonstrated efficacy in patients with mismatch repair-deficient (dMMR), surgically resectable endometrial cancer, according to findings presented at the SGO 2025 Annual ...

Dual checkpoint inhibitors led to longer overall survival in patients with high-risk endometrial cancer who displayed ...

This case underscores the rare coexistence of serous cystadenofibroma in one ovary and collision features involving serous and mucinous cysts in the ...

Single-cell characterization of healthy fallopian tubes revealed shifts in cell and gene expression throughout the menstrual ...

Association Between Human Epidermal Growth Factor Receptor 2-Low Status and Time to Development of Brain Metastases Among Patients With Breast Cancer: A Retrospective Cohort Study A nationwide ...

Partnership to evaluate Mindpeak Breast H&E AI software for primary breast cancer diagnosis in Brazil, Egypt, and Kenya HAMBURG, Germany--(BUSINESS WIRE)--The collaboration aims to assess the ...

A phase III trial of P-Sam versus physician's choice of chemotherapy is planned that will include patients with B7-H4-positive endometrial cancer whose ... seen in multiple histology types ...

ECgMLP generalizes well across multiple histopathology datasets, thereby making it a robust and clinically applicable solution for endometrial cancer diagnosis." Co-author and CDU adjunct ...

A novel two-drug combination exhibited antitumor activity among certain women with advanced endometrial cancer ... of these patients had endometrioid histology, and 15% had unknown mismatch ...